Detailed disclosure is attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Gujarat Terce Laboratories Ltd has approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a period of 5 years, from 28 October 2026 to 27 October 2031. This re-appointment is subject to shareholder approval at the upcoming 41st Annual General Meeting. Mr. Prajapati has over 15 years of experience in the pharmaceutical sector and has been actively involved in the company's leadership and growth initiatives. The disclosure also confirms that Mr. Prajapati is the son of Mr. Natwarbhai Prajapati, who serves as the Whole-Time Director of the Company, indicating a promoter family connection in key leadership roles.
This is a continuity announcement rather than a change in leadership, which may be viewed positively by investors as it provides stability in executive leadership. However, the continued appointment of a promoter family member in the top leadership position reinforces family control over the company's management.